Amedica Corporation (NASDAQ:AMDA) Files An 8-K Other Events

Amedica Corporation (NASDAQ:AMDA) Files An 8-K Other Events

Story continues below

Item 8.01 Other Events.

On November 22, 2016, Amedica Corporation issued a press release
announcing the appointment of Dana Lyons as Vice President of
Sales and Marketing and separately, that the company has been
notified by the FDA regarding the companys Valeo C CsC and Taurus
pedicle screw 510(k) premarket applications. A copy of the press
release is attached hereto as Exhibit 99.1 and is incorporated
herein by reference.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.

99.1 Press Release dated November 22, 2016


About Amedica Corporation (NASDAQ:AMDA)

Amedica Corporation is a commercial biomaterial company. The Company is a vertically integrated silicon nitride orthopedic medical device manufacturer. It is focused on using its silicon nitride ceramic technology platform to develop, manufacture and sell a range of medical devices. It is also engaged in developing wear- and corrosion-resistant implant components for hip and knee arthroplasty. The Company markets its Valeo family of silicon nitride interbody spinal fusion devices in the United States, Europe and Brazil for use in the cervical and thoracolumbar areas of the spine. In addition to its silicon nitride-based spinal fusion products, it markets a line of non-silicon nitride spinal surgery products, which allows the Company to provide surgeons and hospitals with a solution for spinal procedures. Its Valeo interbody spinal fusion devices include Anterior Lumbar, Posterior Lumbar, Oblique Lumbar, Transforaminal Lumbar, Lateral Lumbar, Cervical and Corpectomy.

Amedica Corporation (NASDAQ:AMDA) Recent Trading Information

Amedica Corporation (NASDAQ:AMDA) closed its last trading session down -0.250 at 0.800 with 5,629,037 shares trading hands.

An ad to help with our costs